ArticleDiagnostic and interventional radiology (Ankara, Turkey)2025
Diffusion kurtosis versus diffusion-weighted magnetic resonance imaging in differentiating clear cell renal cell carcinoma and renal angiomyolipoma with minimal fat: a comparative study.
Article in Diagnostic and interventional radiology (Ankara, Turkey), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo quantitatively compare the diagnostic values of conventional diffusion-weighted imaging and diffusion kurtosis imaging (DKI) in differentiating clear cell renal cell carcinoma (ccRCC) and renal angiomyolipoma with minimal fat (RAMF).
methodsSixty-eight patients with ccRCC and 18 patients with RAMF were retrospectively studied. For DKI and apparent diffusion coefficient (ADC), respiratory-triggered echo-planar imaging sequences were acquired in the axial plane (three
resultsThe ADC and MD values of ccRCCs were higher than those of RAMFs (
conclusionDKI analysis demonstrates superior performance than ADC analysis in differentiating ccRCC and RAMF. CLINICAL SIGNIFICANCE: DKI technology may serve as an additional non-invasive biomarker for the differential diagnosis of renal tumor types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.